1-3 of 3
Limin Shang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

NI-3201 Is a Bispecific Antibody Mediating PD-L1–Dependent CD28 Co-stimulation on T Cells for Enhanced Tumor Control

Sara Majocchi, Pauline Lloveras, Lise Nouveau, Margaux Legrand, Alizee Viandier, Pauline Malinge, Maud Charreton, Cecile Raymond, Emily A. Pace, Bjorn L. Millard, L. Anders Svensson, Vinardas Kelpšas, Nadia Anceriz, Susana Salgado-Pires, Bruno Daubeuf, Giovanni Magistrelli, Franck Gueneau, Valéry Moine, Krzysztof Masternak, Limin Shang, Nicolas Fischer, Walter G. Ferlin
Journal: Cancer Immunology Research
Cancer Immunol Res OF1–OF19.
https://doi.org/10.1158/2326-6066.CIR-24-0298
Published: 06 January 2025
View article titled, NI-3201 Is a Bispecific Antibody Mediating PD-L1–Dependent CD28 Co-stimulation on T Cells for Enhanced Tumor Control
Open the PDF for NI-3201 Is a Bispecific Antibody Mediating PD-L1–Dependent CD28 Co-stimulation on T Cells for Enhanced Tumor Control in another window
Includes: Supplementary data
Journal Articles

Abstract A088: Selective blockage of the innate immune checkpoint receptor CD47 on mesothelin (MSLN) positive solid tumor cells via dual targeting bispecific antibodies alters the tumor microenvironment to control tumor growth

Stefano Majocchi, Valéry Moine, Xavier Chauchet, Lucile Broyer, Laura Cons, Laurence Chatel, Eric Hatterer, Vanessa Buatois, Hasnaà Haddouk, Gérard Didelot, Giovanni Magistrelli, Yves Poitevin, Ulla Ravn, Anne Papaioannou, Françoise Richard, Limin Shang, Marie H. Kosco-Vilbois, Nicolas Fischer, Walter G. Ferlin, Krzysztof Masternak
Journal: Cancer Immunology Research
Cancer Immunol Res (2019) 7 (2_Supplement): A088.
https://doi.org/10.1158/2326-6074.CRICIMTEATIAACR18-A088
Published: 01 February 2019
View article titled, Abstract A088: Selective blockage of the innate immune checkpoint receptor CD47 on mesothelin (MSLN) positive solid tumor cells via dual targeting bispecific antibodies alters the tumor microenvironment to control tumor growth
Journal Articles

Abstract B37: NI-1701, a bispecific antibody for selective neutralization of CD47 in B cell malignancies

Krzysztof Masternak, Xavier Chauchet, Vanessa Buatois, Susana Salgado-Pires, Limin Shang, Zoë Johnson, Elie Dheilly, Valéry Moine, Walter G. Ferlin, Marie H. Kosco-Vilbois, Nicolas Fischer
Journal: Cancer Immunology Research
Cancer Immunol Res (2017) 5 (3_Supplement): B37.
https://doi.org/10.1158/2326-6074.TUMIMM16-B37
Published: 28 February 2017
View article titled, Abstract B37: NI-1701, a bispecific antibody for selective neutralization of CD47 in B cell malignancies